Technology areas: Biotechnology & Pharmaceuticals • Communications
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
National Institutes of Health, U.S. Dept. of Health and Human Services, U.S. Government has 4 pending office actions in Biotechnology & Pharmaceuticals. The matters are spread among 4 distinct examiners and 4 distinct art units, indicating broad assignment dispersion across the portfolio.
HAGHIGHATIAN, MINA is the busiest examiner, with 1 pending office action. Counsel should manage the matters as separate examination tracks and monitor for opportunities to keep technical positions consistent.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 4 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HAGHIGHATIAN, MINA | 1 | 46.0% | +39.4% |
| ANSARI, TAHMINA N | 1 | 85.4% | +18.5% |
| AEDER, SEAN E | 1 | 56.9% | +20.0% |
| GANGLE, BRIAN J | 1 | 76.8% | +14.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18852335 | METHODS AND COMPOSITIONS FOR POTENTIATION OF A LIGAND | HAGHIGHATIAN, MINA | — |
| 18825923 | SYSTEMS AND METHODS FOR LEARNING ANATOMICALLY CONSISTENT EMBEDDING FOR CHEST RADIOGRAPHY | ANSARI, TAHMINA N | — |
| 18552417 | PEPTIDES AND ENGINEERED T CELL RECEPTORS TARGETING SARS-COV-2 ANTIGENS AND METHODS OF USE | AEDER, SEAN E | — |
| 18217857 | BACTERIAL BIOFILMS AND CANCER | GANGLE, BRIAN J | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18852335 | METHODS AND COMPOSITIONS FOR POTENTIATION OF A LIGAND | HAGHIGHATIAN, MINA | — |
| 18825923 | SYSTEMS AND METHODS FOR LEARNING ANATOMICALLY CONSISTENT EMBEDDING FOR CHEST RADIOGRAPHY | ANSARI, TAHMINA N | — |
| 18552417 | PEPTIDES AND ENGINEERED T CELL RECEPTORS TARGETING SARS-COV-2 ANTIGENS AND METHODS OF USE | AEDER, SEAN E | — |
| 18217857 | BACTERIAL BIOFILMS AND CANCER | GANGLE, BRIAN J | — |
| Art Unit | Apps |
|---|---|
| 1616 | 1 |
| 2674 | 1 |
| 1642 | 1 |
| 1645 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18852335 | METHODS AND COMPOSITIONS FOR POTENTIATION OF A LIGAND | HAGHIGHATIAN, MINA | 1616 | §102§103§112Other | Non-Final OA | — | Pending | Sep 27, 2024 |
| 18825923 | SYSTEMS AND METHODS FOR LEARNING ANATOMICALLY CONSISTENT EMBEDDING FOR CHEST RADIOGRAPHY | ANSARI, TAHMINA N | 2674 | §102§103 | Non-Final OA | — | Pending | Sep 05, 2024 |
| 18552417 | PEPTIDES AND ENGINEERED T CELL RECEPTORS TARGETING SARS-COV-2 ANTIGENS AND METHODS OF USE | AEDER, SEAN E | 1642 | §102§112 | Final Rejection | — | Pending | Sep 25, 2023 |
| 18217857 | BACTERIAL BIOFILMS AND CANCER | GANGLE, BRIAN J | 1645 | §102§103§112Other | Non-Final OA | — | Pending | Jul 03, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialNational Institutes of Health (nih), U.s. Dept. of Health and Human Services (dhhs), U.s. Government has 4 pending office actions as of October 2026, spread across 4 art units and 4 examiners.
Mina Haghighatian has the most, with 1 of National Institutes of Health (nih), U.s. Dept. of Health and Human Services (dhhs), U.s. Government's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
